Zagreb

Zagreb is rapidly emerging as a premier life sciences hub in Southeast Europe, anchored by a history in pharmaceutical manufacturing and world-class academic research.

The city is best known as the home of Pliva, one of the largest generic pharmaceutical companies in the region, which solidified Zagreb's reputation for high-quality R&D and drug development.

Beyond heritage brands, the Zagreb biotechnology sector is thriving, driven by a new wave of startups and established firms focusing on regenerative medicine, molecular biology and advanced diagnostics.

The University of Zagreb, the nation’s largest research institution, serves as a vital pipeline for talent, contributing over half of Croatia’s total scientific output in biomedicine and life sciences.

This academic excellence is complemented by the Ruđer Bošković Institute, which offers extensive infrastructure for clinical trials and cutting-edge genetic research.

A growing cluster of companies specializing in medical device engineering and digital health solutions is positioning Zagreb as a destination for healthcare innovation.

The city also hosts the EIT Health Hub for Croatia, fostering a collaborative environment for healthtech accelerators and public-private partnerships.

Backed by increasing VC funding and a robust network of contract research organizations (CROs) like Optimapharm and Ergomed, the local ecosystem is accelerating the commercialization of biotech patents.

This unique combination of industrial legacy and modern medtech excellence makes Zagreb a critical node for global investors seeking scalable opportunities in the European life sciences market.

With its strategic location and a dense network of university hospitals, Zagreb remains the primary driver of regional healthcare advancements and biopharmaceutical production.